Lehrstuhl für Genetik

Erweiterung des Repertoires chimärer Antigenrezeptoren (CARs) zur Tumorabwehr: Neue Effektoren und neue Aktivierungswege Oct. 1, 2022 - Oct. 1, 2025 Einfluss zellulärer und humoraler Immunkomponenten in den initialen Phasen der RA (TP 06) PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis Jan. 1, 2022 - Dec. 31, 2024 Mapping the effector response space of antibody combination Dec. 18, 2019 - Nov. 30, 2024 Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. (HYPERBOOST) HYPERBOOST: Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. Dec. 1, 2020 - Nov. 30, 2024 Consortium for Immunotherapeutics against Emerging Viral Threats May 1, 2019 - April 30, 2024 Inducing long-lasting HIV Env-specific antibody responses by intrastructural help Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention Oct. 1, 2019 - March 31, 2024 IMPACT OF a2,6-LINKED SIALIC ACID RESIDUES ON B CELL DEVELOPMENT AND ANTIBODY FUNCTION IN VIVO (TP 3) Sialinsäure als Regulator in Entwicklung und Immunität July 1, 2020 - June 30, 2023 Pathogenicity of IgA-type autoantibodies in pemphigoid disease June 1, 2020 - May 31, 2023 IgG glycosylation as a regulative factor controlling onset of RA (TP 06 / FOR2886) Aug. 1, 2019 - July 31, 2022 Projekt B2: Die IgG Glykosylierung in der Regulation der rheumatoiden Arthritis (TP 06) July 1, 2019 - June 30, 2022